Indications And Dose
Invasive candidiasis ▶BY INTRAVENOUS INFUSION ▶Adult: Initially 200 mg once daily for 1 day, then 100 mg once daily
PDF page 649
Loading InternPractice…
Drug reference
Invasive candidiasis ▶BY INTRAVENOUS INFUSION ▶Adult: Initially 200 mg once daily for 1 day, then 100 mg once daily
PDF page 649
▶Common or very common Bronchospasm. cholestasis. diarrhoea. dyspnoea. headache. hyperglycaemia. hypertension. hypokalaemia. hypotension. nausea. seizure. skin reactions. vomiting ▶Uncommon Abdominal pain upper. coagulation disorder. vasodilation
PDF page 649
Manufacturer advises avoid unless potential benefit outweighs risk—toxicity in animal studies.
PDF page 649
Manufacturer advises avoid unless potential benefit outweighs risk—present in milk in animal studies.
PDF page 649
For intravenous infusion (Ecalta ®), give intermittently in Glucose 5% or Sodium chloride 0.9%. Reconstitute each 100 mg with 30 mL water for injections and allow up to 5 minutes for reconstitution; dilute dose in infusion fluid to a concentration of 770 micrograms/mL; give at a rate not exceeding 1.1 mg/minute. Follow product information if using stock supplied with ethanol solvent.
PDF page 649
There can be variation in the licensing of different medicines containing the same drug. Powder for solution for infusion ▶Anidulafungin (Non-proprietary) Anidulafungin 100 mg Anidulafungin 100mg powder for concentrate for solution for infusion vials | 1 vial P £299.98 DT = £296.23 (Hospital only) ▶Ecalta (Pfizer Ltd) Anidulafungin 100 mg Ecalta 100mg powder for concentrate for solution for infusion vials | 1 vial P £299.99 DT = £296.23 (Hospital only)
PDF page 649
Initially 200 mg once daily for 1 day, then
First-line fragment. Read the complete Indications and Dose section above.
PDF page 649